These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 27905583)
21. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis. Wawruszak A; Luszczki JJ; Grabarska A; Gumbarewicz E; Dmoszynska-Graniczka M; Polberg K; Stepulak A PLoS One; 2015; 10(11):e0143013. PubMed ID: 26580554 [TBL] [Abstract][Full Text] [Related]
22. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin. Greco O; Powell TM; Marples B; Joiner MC; Scott SD Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381 [TBL] [Abstract][Full Text] [Related]
23. Inelastic neutron scattering study of confined surface water on rutile nanoparticles. Spencer EC; Levchenko AA; Ross NL; Kolesnikov AI; Boerio-Goates J; Woodfield BF; Navrotsky A; Li G J Phys Chem A; 2009 Mar; 113(12):2796-800. PubMed ID: 19243118 [TBL] [Abstract][Full Text] [Related]
24. Modulation of the sensitivity in Chinese hamster cells to photons and fast neutrons by cisplatin, vinblastine, and bleomycin. Mokaleng BB; Akudugu JM Can J Physiol Pharmacol; 2009 May; 87(5):347-52. PubMed ID: 19448732 [TBL] [Abstract][Full Text] [Related]
25. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874 [TBL] [Abstract][Full Text] [Related]
26. Cisplatin/hydrogel complex in cancer therapy. Casolaro M; Cini R; Del Bello B; Ferrali M; Maellaro E Biomacromolecules; 2009 Apr; 10(4):944-9. PubMed ID: 19254026 [TBL] [Abstract][Full Text] [Related]
27. Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer. Yu H; Guo C; Feng B; Liu J; Chen X; Wang D; Teng L; Li Y; Yin Q; Zhang Z; Li Y Theranostics; 2016; 6(1):14-27. PubMed ID: 26722370 [TBL] [Abstract][Full Text] [Related]
28. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Foroodi F; Duivenvoorden WC; Singh G Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028 [TBL] [Abstract][Full Text] [Related]
29. Polymeric micelles for pH-responsive delivery of cisplatin. Shahin M; Safaei-Nikouei N; Lavasanifar A J Drug Target; 2014 Aug; 22(7):629-37. PubMed ID: 24878378 [TBL] [Abstract][Full Text] [Related]
30. Determination of neutron energy spectra inside a water phantom irradiated by 64 MeV neutrons. Herbert MS; Brooks FD; Allie MS; Buffler A; Nchodu MR; Makupula SA; Jones DT; Langen KM Radiat Prot Dosimetry; 2007; 126(1-4):346-9. PubMed ID: 17545657 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of amphiphilic polythiophene for cell imaging and monitoring the cellular distribution of a cisplatin anticancer drug. Tang H; Xing C; Liu L; Yang Q; Wang S Small; 2011 May; 7(10):1464-70. PubMed ID: 21506263 [TBL] [Abstract][Full Text] [Related]
32. Inelastic neutron scattering studies of the interaction between water and some amino acids. Zhang Y; Zhang P; Ford RC; Han S; Li J J Phys Chem B; 2005 Sep; 109(38):17784-6. PubMed ID: 16853278 [TBL] [Abstract][Full Text] [Related]
33. A model for water motion in crystals of lysozyme based on an incoherent quasielastic neutron-scattering study. Bon C; Dianoux AJ; Ferrand M; Lehmann MS Biophys J; 2002 Sep; 83(3):1578-88. PubMed ID: 12202382 [TBL] [Abstract][Full Text] [Related]
34. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Ishida S; Lee J; Thiele DJ; Herskowitz I Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14298-302. PubMed ID: 12370430 [TBL] [Abstract][Full Text] [Related]
35. Water dynamics in human cancer and non-cancer tissues. Marques MPM; Santos IP; Batista de Carvalho ALM; Mamede AP; Martins CB; Figueiredo P; Sarter M; Sakai VG; Batista de Carvalho LAE Phys Chem Chem Phys; 2022 Jun; 24(25):15406-15415. PubMed ID: 35704895 [TBL] [Abstract][Full Text] [Related]
36. Celecoxib antagonizes the cytotoxic effect of cisplatin in human gastric cancer cells by decreasing intracellular cisplatin accumulation. Chen M; Yu L; Gu C; Zhong D; Wu S; Liu S Cancer Lett; 2013 Feb; 329(2):189-96. PubMed ID: 23142285 [TBL] [Abstract][Full Text] [Related]
37. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines]. Cheng G; Li Y; Tian F Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113 [TBL] [Abstract][Full Text] [Related]
38. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells. Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708 [TBL] [Abstract][Full Text] [Related]
39. Star-shaped nano-conjugates of cisplatin with high drug payload. Kowalczuk A; Stoyanova E; Mitova V; Shestakova P; Momekov G; Momekova D; Koseva N Int J Pharm; 2011 Feb; 404(1-2):220-30. PubMed ID: 21078377 [TBL] [Abstract][Full Text] [Related]
40. Increase of intracellular cisplatin levels and radiosensitization by ultrasound in combination with microbubbles. Lammertink BHA; Bos C; van der Wurff-Jacobs KM; Storm G; Moonen CT; Deckers R J Control Release; 2016 Sep; 238():157-165. PubMed ID: 27476609 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]